title: Comparison of alvogyl, SaliCept patch, and low-level laser therapy in the management of alveolar osteitis.
abstract: OBJECTIVE
  The aim of the present randomized prospective clinical trial was to compare the effects of alvogyl, the SaliCept patch, and low-level laser therapy in the management of alveolar osteitis.
  
  
  METHODS
  The study population included 104 patients who had been referred to our clinic with a complaint of alveolar osteitis. The patients were randomly assigned to 1 of 4 groups: group 1, curettage and irrigation alone; group 2, curettage and irrigation followed by alvogyl applied directly to the socket; group 3, curettage and irrigation followed by a SaliCept patch applied directly to the socket; and group 4, curettage and irrigation followed by continuous-mode diode laser irradiation (808 nm, 100 mW, 60 seconds, 7.64 J/cm(2)). The treatment procedures were repeated after 3 days. The clinical signs and symptoms for each patient were recorded at diagnosis, at 3 days after the diagnosis, and at 7 days after the diagnosis. In addition, the pain intensity levels for each patient were recorded at diagnosis and daily for 7 days after the initial treatment.
  
  
  RESULTS
  No statistically significant differences in the management of alveolar osteitis were observed between groups 2 and 3. However, the management of alveolar osteitis was significantly better in group 4 than in the other 3 groups.
  
  
  CONCLUSIONS
  Within the limitations of the present study, it can be concluded that acemannan in the form of the SaliCept patch is an acceptable alternative to alvogyl as a dressing for the management of alveolar osteitis. However, low-level laser therapy treatment at 7.64 J/cm(2) (0.1 W × 60 seconds = 6 J) performed superiorly to both SaliCept and alvogyl in managing alveolar osteitis in our study population.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Atatürk University, Faculty of Dentistry, Erzurum, Turkey. kayamahir@gmail.com
authors.forename: Göksel Şimşek
authors.initials: GŞ
authors.lastname: Kaya
authors.forename: Günay
authors.initials: G
authors.lastname: Yapici
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Savaş
authors.forename: Metin
authors.initials: M
authors.lastname: Güngörmüş
mesh_terms: D000328:Adult; D057914:Agricultural Irrigation; D062365:Aminobenzoates / Q000627:therapeutic use*; D001458:Bandages; D003475:Curettage; D004338:Drug Combinations; D004368:Dry Socket / Q000628:therapy*; D005054:Eugenol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006847:Hydrocarbons, Iodinated / Q000627:therapeutic use*; D028022:Low-Level Light Therapy; D008297:Male; D008351:Mannans / Q000627:therapeutic use*; D009822:Oils, Volatile / Q000627:therapeutic use*; D010147:Pain Measurement; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D062366:para-Aminobenzoates
chemical_list: D062365:Aminobenzoates; D004338:Drug Combinations; D006847:Hydrocarbons, Iodinated; D008351:Mannans; D009822:Oils, Volatile; D010936:Plant Extracts; C013804:butyl aminobenzoate, eugenol, iodoform, spearmint oil drug combinations; D062366:para-Aminobenzoates; D005054:Eugenol; C058414:acemannan